Riskpilot← Back to searchSign inGet full accessHIPAQ A/S
A/SActiveCVR 13716137Vidalsvej 4Wholesale of other machinery and equipment · NACE 4664Est. 19908 employees
Revenue 2025
DKK 5M
-32% vs 2024
EBITDA margin
2.0%
-96% vs 2024
Equity ratio
49.4%
Financial strength
Net profit 2025
DKK 543K
-81% vs 2024
| Revenue | DKK 5M | -32% |
| EBITDA | DKK 99K | -96% |
| Net profit | DKK 543K | -81% |
| Total assets | DKK 17M | -24% |
| Equity | DKK 8,4M | +7% |
| Employees | 8 | — |
Legal name
HIPAQ A/S
CVR number
13716137
Legal form
Aktieselskab
NACE code
4664 · Wholesale of other machinery and equipment
Founded
1. januar 1990
Share capital
DKK 500.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening eller af tre medlemmer af bestyrelsen i forening.
Company purpose
Selskabets formål er at drive ingeniør-, handels- og servicevirksomhed og anden virksomhed, som efter bestyrelsens skøn står i forbindelse hermed
Address
Vidalsvej 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.183 | 21.471 | 10.673 | 28.371 | 24.166 | 8.628 | 2.631 | 10.382 | 14.451 | 7.370 | 3.505 | 2.045 | 7.300 | 4.990 |
| Staff expenses | -4.198 | -10.094 | -6.747 | -11.080 | -10.494 | -6.386 | -4.760 | -4.204 | -5.120 | -4.628 | -4.615 | -4.545 | -4.780 | -4.891 |
| EBITDA | 8.985 | 11.377 | 3.925 | 17.291 | 13.672 | 2.420 | -2.130 | 6.178 | 9.303 | 2.743 | -1.109 | -2.500 | 2.520 | 99 |
| Depreciation & amort. | -211 | 471 | 176 | 275 | -17 | 89 | -63 | -66 | -63 | -60 | -22 | -44 | -63 | -56 |
| EBIT | 8.774 | 10.906 | 3.749 | 17.016 | 13.654 | 2.331 | -2.192 | 6.113 | 9.240 | 2.683 | -1.131 | -2.544 | 2.457 | 43 |
| Net financials | 530 | 310 | -276 | -414 | -189 | 252 | 193 | 41 | 580 | 361 | 331 | 338 | 932 | 537 |
| Profit before tax | 9.304 | 11.216 | 3.473 | 16.602 | 13.465 | 2.583 | -1.999 | 6.154 | 9.820 | 3.043 | -801 | -2.206 | 3.389 | 579 |
| Tax | 2.175 | 2.695 | 797 | 3.914 | 3.001 | 520 | -490 | 1.323 | 2.016 | 580 | -281 | -582 | 553 | 37 |
| Net profit | 7.080 | 8.521 | 2.676 | 12.688 | 10.464 | 2.063 | -1.509 | 4.831 | 7.804 | 2.463 | -519 | -1.624 | 2.835 | 543 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 19.302 | 24.546 | 31.094 | 34.557 | 34.066 | 17.677 | 10.557 | 17.049 | 25.983 | 19.271 | 14.779 | 16.022 | 22.201 | 16.979 |
| Equity | 11.080 | 13.541 | 7.562 | 17.643 | 15.439 | 7.054 | 3.496 | 8.315 | 13.058 | 7.540 | 4.509 | 5.006 | 7.860 | 8.381 |
| Long-term debt | 0 | 0 | 0 | 0 | 3.490 | 411 | 0 | 468 | 2.765 | 665 | 0 | 0 | 0 | 558 |
| Short-term debt | 8.131 | 10.969 | 23.163 | 16.320 | 15.031 | 9.998 | 7.062 | 7.648 | 9.914 | 10.913 | 10.270 | 11.016 | 13.563 | 7.784 |
| Total debt | 8.131 | 10.969 | 23.163 | 16.320 | 18.521 | 10.410 | 7.062 | 8.116 | 12.679 | 11.579 | 10.270 | 11.016 | 13.563 | 8.343 |
EBITDA margin
2.0%
This company
15.8%
Market median
-87% vs market
20122025
Equity ratio
49.4%
This company
38.2%
Market median
+29% vs market
20122025
Return on equity
6.5%
This company
18.4%
Market median
-65% vs market
20122025
Net profit margin
10.9%
This company
8.1%
Market median
+35% vs market
20122025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20122025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LL Management | Management | 2002 | — | — |
JL Management | Management | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1990 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 1990 | — | — | |
| Board of Directors | 1990 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
XL Invest ApS | Company | 100.0% | 100.0% | 1997 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
XL Invest ApS
HIPAQ A/S Board members of HIPAQ A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Lindberg | Management | 0 companies |
| Jesper Lindberg | Management | 0 companies |
| Svend Jørgen Olesen | Board of Directors | 0 companies |
| Mads Balsby Wilkens | Chairman | 0 companies |
| Torben Voss | Board of Directors | 0 companies |
| Karen Olesen | Board of Directors | 0 companies |